5,7-Difluoro-1H-indole-2-carboxylic acid, 95.0%, 25g

Molybdenum(VI) oxide, min. 99.8%, pa, 250 g, plastic packaging.

3-(aminomethyl)-5-chloropyridin-2-amine, 97%, 500mg

(R)-7-(But-2-ynyl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, 98%, 250mg

(6-Phenylnaphthalen-2-yl)boronic acid, 95.0%, 25g

1-Naphthaldehyde, 97.0%, 1kg

2-(4-Trifluoromethylphenyl)-4-chloromethyl-5-methyloxazole, 95.0%, 250mg

(4-Hydroxyphenyl)(pyridin-4-yl)methanone, 98%, 1g

7-Bromo-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 250mg

2-(3-aminopiperidin-1-yl)ethan-1-ol dihydrochloride, 96%, 250mg

2,2'-Dimethyl-[4,4']bipyridinyl, 95%, 1g

4-Bromo-5-fluoro-isoquinoline, 97%, 1g

TASISULAM, 95%, 25mg